{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:05Z","timestamp":1707524945785},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"DOI":"10.7759\/cureus.36292","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T15:30:22Z","timestamp":1679067022000},"source":"Crossref","is-referenced-by-count":0,"title":["An Interesting Imaging Presentation of a Common Benign Entity: Fibrocystic Changes in a Postmenopausal Patient"],"prefix":"10.7759","author":[{"given":"Brittany Q","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan D","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6909.1990.tb01629.x","article-title":"Fibrocystic breast disease. An update and review","volume":"19","author":"Norwood SL","year":"1990","unstructured":"Norwood SL. Fibrocystic breast disease. An update and review. J Obstet Gynecol Neonatal Nurs. 1990, 19:116-21. 10.1111\/j.1552-6909.1990.tb01629.x","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198210143071611","article-title":"Sounding board. Fibrocystic \"disease\" of the breast--a nondisease?","volume":"307","author":"Love SM","year":"1982","unstructured":"Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic \"disease\" of the breast--a nondisease?. N Engl J Med. 1982, 307:1010-4. 10.1056\/NEJM198210143071611","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5530","article-title":"OC122: polycystic ovary syndrome and fibrocystic breast disease: is there any association?","volume":"32","author":"Gumus II","year":"2008","unstructured":"Gumus II, Koktener A, Dogan D, Turhan NO. OC122: polycystic ovary syndrome and fibrocystic breast disease: is there any association?. Ultrasound Obstet Gynecol. 2008, 32:283. 10.1002\/uog.5530","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02547-5","article-title":"The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis","volume":"22","author":"Kohnepoushi P","year":"2022","unstructured":"Kohnepoushi P, Dehghanbanadaki H, Mohammadzedeh P, Nikouei M, Moradi Y. The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis. Cancer Cell Int. 2022, 22:125. 10.1186\/s12935-022-02547-5","journal-title":"Cancer Cell Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-62539-3_4707","article-title":"Fibrocystic breast changes","author":"Castellano I","year":"2020","unstructured":"Castellano I, Metovic J. Fibrocystic breast changes. Breast Pathology. Sapino A, Kulka J (ed): Springer Cham, New York City, NY; 2020. 110-6. 10.1007\/978-3-319-62539-3_4707"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/raon-2017-0016","article-title":"Breast dynamic contrast enhanced MRI: fibrocystic changes presenting as a non-mass enhancement mimicking malignancy","volume":"51","author":"Milosevic ZC","year":"2017","unstructured":"Milosevic ZC, Nadrljanski MM, Milovanovic ZM, Gusic NZ, Vucicevic SS, Radulovic OS. Breast dynamic contrast enhanced MRI: fibrocystic changes presenting as a non-mass enhancement mimicking malignancy. Radiol Oncol. 2017, 51:130-6. 10.1515\/raon-2017-0016","journal-title":"Radiol Oncol"},{"key":"ref7","article-title":"Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists","volume":"122","author":"Fitzgibbons PL","year":"1998","unstructured":"Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998, 122:1053-5.","journal-title":"Arch Pathol Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(18)31247-9","article-title":"Estrogen replacement therapy and fibrocystic breast disease","volume":"3","author":"Pastides H","year":"1987","unstructured":"Pastides H, Najjar MA, Kelsey JL. Estrogen replacement therapy and fibrocystic breast disease. Am J Prev Med. 1987, 3:282-6. 10.1016\/S0749-3797(18)31247-9","journal-title":"Am J Prev Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0380","article-title":"Estrogen plus progestin and risk of benign proliferative breast disease","volume":"17","author":"Rohan TE","year":"2008","unstructured":"Rohan TE, Negassa A, Chlebowski RT, et al.. Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol Biomarkers Prev. 2008, 17:2337-43. 10.1158\/1055-9965.EPI-08-0380","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.4.302","article-title":"Effects of tamoxifen on benign breast disease in women at high risk for breast cancer","volume":"95","author":"Tan-Chiu E","year":"2003","unstructured":"Tan-Chiu E, Wang J, Costantino JP, et al.. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst. 2003, 95:302-7. 10.1093\/jnci\/95.4.302","journal-title":"J Natl Cancer Inst"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2018.57.04.18","article-title":"The role of E2\/P ratio in the etiology of fibrocystic breast disease, mastalgia and mastodynia","volume":"57","author":"Brki\u0107 M","year":"2018","unstructured":"Brki\u0107 M, Vujovi\u0107 S, Ivovi\u0107 M, Tan\u010di\u0107 Gaji\u0107 M, Marina L, Frani\u0107 Ivani\u0161evi\u0107 M, Frani\u0107 D. The role of E2\/P ratio in the etiology of fibrocystic breast disease, mastalgia and mastodynia. Acta Clin Croat. 2018, 57:756-61. 10.20471\/acc.2018.57.04.18","journal-title":"Acta Clin Croat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90421-7","article-title":"Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management","volume":"154","author":"Vorherr H","year":"1986","unstructured":"Vorherr H. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. Am J Obstet Gynecol. 1986, 154:161-79. 10.1016\/0002-9378(86)90421-7","journal-title":"Am J Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2016.59.5.367","article-title":"The association between polycystic ovary syndrome and breast cancer: a meta-analysis","volume":"59","author":"Shobeiri F","year":"2016","unstructured":"Shobeiri F, Jenabi E. The association between polycystic ovary syndrome and breast cancer: a meta-analysis. Obstet Gynecol Sci. 2016, 59:367-72. 10.5468\/ogs.2016.59.5.367","journal-title":"Obstet Gynecol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-016-0716-7","article-title":"Polycystic ovarian syndrome (PCOS), related symptoms\/sequelae, and breast cancer risk in a population-based case-control study","volume":"27","author":"Kim J","year":"2016","unstructured":"Kim J, Mersereau JE, Khankari N, et al.. Polycystic ovarian syndrome (PCOS), related symptoms\/sequelae, and breast cancer risk in a population-based case-control study. Cancer Causes Control. 2016, 27:403-14. 10.1007\/s10552-016-0716-7","journal-title":"Cancer Causes Control"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/jmh.jmh_8_21","article-title":"Polycystic ovarian syndrome and menopause in forty-plus women","volume":"12","author":"Sharma S","year":"2021","unstructured":"Sharma S, Mahajan N. Polycystic ovarian syndrome and menopause in forty-plus women. J Midlife Health. 2021, 12:3-7. 10.4103\/jmh.jmh_8_21","journal-title":"J Midlife Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0039","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS","volume":"96","author":"Puurunen J","year":"2011","unstructured":"Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, J\u00e4rvel\u00e4 I, Ruokonen A, Tapanainen JS. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab. 2011, 96:1827-34. 10.1210\/jc.2011-0039","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann LC","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, et al.. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005, 353:229-37. 10.1056\/NEJMoa044383","journal-title":"N Engl J Med"},{"key":"ref18","article-title":"Cystic breast masses and the ACRIN 6666 experience","volume":"48","author":"Berg WA","year":"2010","unstructured":"Berg WA, Sechtin AG, Marques H, Zhang Z. Cystic breast masses and the ACRIN 6666 experience. Radiol Clin North Am. 2010, 48:931-87.","journal-title":"Radiol Clin North Am"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019182599","article-title":"Growth dynamics of mammographic calcifications: differentiating ductal carcinoma in situ from benign breast disease","volume":"292","author":"Grimm LJ","year":"2019","unstructured":"Grimm LJ, Miller MM, Thomas SM, et al.. Growth dynamics of mammographic calcifications: differentiating ductal carcinoma in situ from benign breast disease. Radiology. 2019, 292:77-83. 10.1148\/radiol.2019182599","journal-title":"Radiology"},{"key":"ref20","article-title":"Fibrocystic Breast Disease","author":"Malherbe K","year":"2022","unstructured":"Malherbe K, Khan M, Fatima S. Fibrocystic Breast Disease. StatPearls Publishing, Treasure Island, FL; 2022."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144464-an-interesting-imaging-presentation-of-a-common-benign-entity-fibrocystic-changes-in-a-postmenopausal-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:51Z","timestamp":1707508491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144464-an-interesting-imaging-presentation-of-a-common-benign-entity-fibrocystic-changes-in-a-postmenopausal-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.36292","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}